home | about us | attorneys | actos | bladder cancer | faqs | articles | law resources | press release | contact us | blog | Log in
Copyright ©2007-2010 Williams Kherkher. Attorneys are licensed only in the state of Texas unless otherwise indicated in the biographical section. Past performance is no guarantee of future results. Williams Kherkher's primary office is located in Texas. Terms of Use. Disclaimer. Sitemap.
8441 Gulf Freeway, Suite 600, Houston, TX 77017-5051 -- 800-641-9810 | John Eddie Williams +
Consumers question diabetes medications
Posted on November 30th, 2011
No Comments
A class of diabetes medications has consumers concerned about long term use on the class of drugs as a whole. Type 2 diabetes occurs when the body does not make enough insulin or the cells in the body ignore the insulin. There is a category of medication that helps the liver and muscle tissueso what [...]
The FDA on Actos
Posted on November 28th, 2011
No Comments
The Food and Drug Administration has been investigating the use of the type 2 diabetes medication, Actos, since September 2010. In June 2011, the FDA announced that medications containing the ingredient pioglitazone( an active ingredient in Actos) must have a warning label on them about extended use of the medication and its link to bladder [...]
Bladder cancer: Statistics and Facts
Posted on November 21st, 2011
No Comments
Bladder cancer can have multiple painful side effects and it can be potentially fatal if not treated in time. There are a few important facts and statistics that are important to note. For example, over 65,000 people a year are diagnosed with this type of cancer. Of these people, men are three times more likely [...]
Takeda to conduct 10-year study on Actos and bladder cancer
Posted on November 18th, 2011
No Comments
After the Food and Drug Administration warned consumers that the Type 2 diabetes medication, Actos, has been linked to an increased risk of bladder cancer, the drug’s maker, Takeda Pharmaceuticals, announced that they will be conducting a 10-year study into this link. The study will involve the observation of diabetes patients. The 193, 099 participants [...]
What is Type 2 diabetes?
Posted on November 16th, 2011
No Comments
Type 2 diabetes is the most common type of diabetes and it occurs when the body does not produce insulin or the body’s cells ignore the insulin. Insulin is very important because the body breaks down the insulin so that it can use glucose for energy. When a person eats, the body breaks down the [...]
Singer Andy Williams diagnosed with bladder cancer
Posted on November 11th, 2011
No Comments
The 83-year-old singer most famously known for the hit song, “It’s the Most Wonderful Time of the Year,” has been diagnosed with bladder cancer. Andy Williams made the announcement while performing in Branson, Missouri. His positive attitude was hard to miss when he made numerous statements revealing he was going to be one of those [...]
Takeda Pharmaceuticals suffering as a result of loss Actos sales
Posted on November 10th, 2011
No Comments
Takeda Pharmaceuticals Co. has announced that their profits are slipping because of the increased evidence that shows that their popular diabetes drug, Actos, is linked to bladder cancer. The link between Actos and bladder cancer was uncovered in September 2010 when the Food and Drug Administration released a 10-year study on the drug and its [...]
Actos sales fall after bladder cancer risk reported
Posted on November 7th, 2011
No Comments
The sales of the type 2 diabetes drug, Actos, have decreased after the reports were released that the drug has been linked to the increased risk of bladder cancer when taken for over a year. The drug makers, Takeda Pharmaceuticals Co., has stated that they have net profit of $1.74 billion for the first part [...]
Takeda to have new diabetes drug reveiwed in January
Posted on November 3rd, 2011
No Comments
Takeda Pharmaceutical Co. will soon find out if another drug to treat type 2 diabetes will be approved for use in January. The Food and Drug Administration has stated that the date of review for alogliptin will be January 25. It will also be reviewed to see if the alogliptin can be combined with Actos [...]
By submitting this form, you certify that you agree to our terms and conditions and wish to be contacted regarding your inquiry.
Archives
- April 2013
- February 2013
- January 2013
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
Categories
- Actos and bladder cancer lawyers (17)
- Actos attorneys (12)
- Actos bladder cancer attorneys (9)
- Actos bladder cancer lawsuit attorneys (9)
- Actos bladder cancer lawsuit lawyers (16)
- Actos bladder cancer lawyers (25)
- Actos lawsuit attorneys (26)
- Actos lawsuit lawyers (24)
- Actos lawyers (8)
- Actos mass tort attorneys (2)
- Actos side effects lawyers (3)
- Bladder Cancer and Actos (1)
- bladder cancer symptoms lawyers (4)
- bladder cancer treatments (1)
- Diabetes drug side effect (3)
- Risk of diabetes (1)
- Takeda Pharmaceuticals (4)
- Uncategorized (1)
Blogroll
- Accutane Lawsuit Attorney
- Depakote Lawyers
- Depuy Lawsuit Attorney
- Mesothelioma Lawyers
- Reglan Lawsuit Attorney
- Topamax Lawsuit Attorney